PTPRC and metastatic colorectal cancer: These results reinforced GAPDH and VIL1 normalized to CD45 as accurate biomarkers for the detection of CTC from metastatic colorectal cancer patients, and further indicate their combination as a more efficient detection method than GAPDH or VIL1 biomarkers individually.